A
Azam Anwar
Researcher at Baylor University Medical Center
Publications - 14
Citations - 219
Azam Anwar is an academic researcher from Baylor University Medical Center. The author has contributed to research in topics: Angioplasty & Coronary artery disease. The author has an hindex of 7, co-authored 14 publications receiving 215 citations.
Papers
More filters
Journal ArticleDOI
Hepatic lipase (LIPC) promoter polymorphism in men with coronary artery disease. Allele frequency and effects on hepatic lipase activity and plasma HDL-C concentrations.
Ralph V. Shohet,Gloria L. Vega,Azam Anwar,Joaquin E. Cigarroa,Scott M. Grundy,Scott M. Grundy,Jonathan Cohen +6 more
TL;DR: The data indicate that a primary decrease in hepatic lipase activity of as much as 30% does not influence susceptibility to CAD in white men.
Journal ArticleDOI
Effect on right ventricular volume of percutaneous Amplatzer closure of atrial septal defect in adults.
Jeffrey M. Schussler,Azam Anwar,Sabrina D. Phillips,Brad J. Roberts,Ravi C. Vallabhan,Paul A. Grayburn +5 more
TL;DR: In adult patients with atrial septal defects, right ventricular cavity size may return to normal after operative closure, and improved RV volumes and right atrial areas after successful transcatheter closure are demonstrated.
Journal ArticleDOI
Mechanism and severity of mitral regurgitation by transesophageal echocardiography in patients referred for percutaneous valve repair.
Paul A. Grayburn,Bradley J. Roberts,Susan Aston,Azam Anwar,Robert F. Hebeler,David L. Brown,Michael J. Mack +6 more
TL;DR: Most patients referred for MitraClip therapy do not have severe enough MR to warrant intervention, and of those with clinical need for intervention, surgery is more often recommended for anatomic or clinical reasons.
Journal ArticleDOI
Plasma platelet-activating factor acetylhydrolase activity is not associated with premature coronary atherosclerosis.
TL;DR: It is concluded that variation in plasma platelet-activating factor acetylhydrolase activity is not a risk factor for coronary artery disease.
Journal ArticleDOI
Distal vessel pullback angiography and pressure gradient measurement: An innovative diagnostic approach to evaluate the no-reflow phenomenon
TL;DR: Pressure gradient measurement with distal vessel pull-back (retrograde) angiography provides maximal information regarding the severity of disease and the etiology of "no-reflow," while exposing both the patient and angiographer to less risk compared to standard strategies.